1993
DOI: 10.1002/med.2610130605
|View full text |Cite
|
Sign up to set email alerts
|

Inhibitors of Aspartyl Proteinases

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
11
0
1

Year Published

1993
1993
2014
2014

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 52 publications
(12 citation statements)
references
References 191 publications
0
11
0
1
Order By: Relevance
“…The inhibitor binds in the activesite cavity in an extended conformation. It is held by a set of hydrophobic and hydrogen-bonding interactions, many of which are conserved in similar structures (Abdel-Meguid, 1993;Wlodawer & Erickson, 1993). Every heteroatom of the inhibitor is hydrogen-bonded to an atom of the protein, either directly or indirectly through a water molecule ( Figure 3).…”
Section: Resultsmentioning
confidence: 99%
“…The inhibitor binds in the activesite cavity in an extended conformation. It is held by a set of hydrophobic and hydrogen-bonding interactions, many of which are conserved in similar structures (Abdel-Meguid, 1993;Wlodawer & Erickson, 1993). Every heteroatom of the inhibitor is hydrogen-bonded to an atom of the protein, either directly or indirectly through a water molecule ( Figure 3).…”
Section: Resultsmentioning
confidence: 99%
“…The inhibitor should be able to lower renin blood pressure in hypertensive patients; be orally bioavailable to compete in the market place with ACE inhibitors; advantageous relative to other antihypertensive agents; potent; specific for renin versus pepsin; nontoxic; and metabolically stable. Progress toward achieving most of these requirements has been substantial and systematic structural modifications lead to molecules with significantly improved properties such as the development of orally bioavailable inhibitors ready for preclinical and clinical trials [152].…”
Section: Renin Inhibitorsmentioning
confidence: 99%
“…A subunidade hidroxietileno do amino ácido não usual statina, presente no derivado (27), pode ser considerado um isóstero adequado para a ligação amídica e foi utilizado como base para o desenvolvimento de inibidores que mimetizavam o estado de transição tetraédrico da hidrólise 30 . Diversos inibidores de HIV protease foram desenvolvidos posteriormente utilizando grupamentos como hidroxietileno, diidroxietileno ou difluorocetonas, entre outros, como isósteros de amida 30,68,71,72 . O isóstero não hidrolizável de amida mais simples, a amida reduzida (alquil amina), não demonstrou ser um grupamento adequado para inibidores de HIV PR 34 .…”
Section: Inibidores De Hiv Proteaseunclassified